XM does not provide services to residents of the United States of America.

Spanish stocks - Factors to watch on Aug 1



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Spanish stocks - Factors to watch on Aug 1</title></head><body>

Aug 1 (Reuters) -The following Spanish stocks may be affected by newspaper reports and other factors on Thursday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy:


CELLNEX CLNX.MC

Spain's Cellnex CLNX.MC on Thursday posted a 5.9% rise in first half adjusted earnings before interest, taxes, depreciation and amortisation to 1.58 billion euros ($1.71 billion) thanks to higher revenues. nL8N3JO0I0


FLUIDRA FLUI.MC

Fluidra said on Thursday its first-half net profit rose to 111.9 million euros compared to 104.1 million euros reported a year ago.

The company also said on Thursday it expected to deliver full year guidance. nFWN3JO0BJ


ROVI ROVI.MC

Rovi said on Thursday it would proceed with share capital reduction through the redemption of 2.8 million treasury shares. nFWN3JN326


MELIA HOTELS MEL.MC

Spanish hotel group Melia MEL.MC reported on Wednesday an 11% rise in first-half net profit to 51.4 million euros ($56 million), beating market expectations, as revenues per room rose over 13% on higher prices and occupancy amid strong demand. nL8N3JN31K


ENCE ENC.MC

ENCE said on Wednesday constitutional court dismissed appeal and confirmed legality of Pontevedra's biofactory extension concession. nL8N3JN37G


TALGO TLGO.MC

Ganz-Mavag has decided to raise to the European Commission "the political and ideological veto of Pedro Sanchez's government on the acquisition of Talgo", Spanish online news website El Confidencial reported on Thursday. Citing EU sources, it added the Hungarian consortium has informed the Brussels authorities of the successive administrative obstacles imposed to try to put the deal on hold.


PHARMA MAR PHMR.MC

Chardan Capital Markets initiates with "buy" rating and target price of 60 euros. nFWN3JO0KK


For today's European market outlook double click on .EU.

For real-time moves on the Spanish blue-chip index IBEX please double click on .IBEX

For IBEX constituent stocks highlight .IBEX in the command box and press the F3 button on your keyboard

For latest news on Spanish stock moves double click HOT-ES

For Spanish language market report double click on .MES

For latest Eurostocks report please double click on .EU


(Gdansk Newsroom; Gdansk.newsroom@thomsonreuters.com
+48 58 769 66 00)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.